Rsf-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 6-10

  Li, Qingchang ^a   Dong, Qianze ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Proliferation; Rsf 1

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RSF 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; COLONY FORMATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 84862807031     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.095     Document Type: Article

References (18)

1. Shih Ie M., Sheu J.J., Santillan A., Nakayama K., Yen M.J., Bristow R.E., Vang R., Parmigiani G., Kurman R.J., Trope C.G., Davidson B., Wang T.L. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc. Natl. Acad. Sci. USA 2005, 102(39):14004-14009.
2. Davidson B., Trope C.G., Wang T.L., Shih Ie M. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival. Gynecol. Oncol. 2006, 103(3):814-819.
3. Mao T.L., Hsu C.Y., Yen M.J., Gilks B., Sheu J.J., Gabrielson E., Vang R., Cope L., Kurman R.J., Wang T.L., Shih Ie M. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Hum. Pathol. 2006, 37(9):1169-1175.
4. F. M. Fang, C. F. Li, H. Y. Huang, M. T. Lai, C. M. Chen, I. W. Chiu, T. L. Wang, F. J. Tsai, M. Shih Ie, and J. J. Sheu, Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma. Am. J. Pathol. 178 (5) p. 2407-2415.
5. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays 1998, 20(6):473-479.
6. H. C. Tai, H. Y. Huang, S. W. Lee, C. Y. Lin, M. J. Sheu, S. L. Chang, L. C. Wu, Y. L. Shiue, W. R. Wu, C. M. Lin, and C. F. Li, Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma. J. Clin. Pathol.
7. Xu J., Tyan T., Cedrone E., Savaraj N., Wang N. Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection. Genes, Chromosomes Cancer 1996, 17(3):172-178.
8. Shibata T., Uryu S., Kokubu A., Hosoda F., Ohki M., Sakiyama T., Matsuno Y., Tsuchiya R., Kanai Y., Kondo T., Imoto I., Inazawa J., Hirohashi S. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin. Cancer Res. 2005, 11(17):6177-6185.
9. Brown L.A., Irving J., Parker R., Kim H., Press J.Z., Longacre T.A., Chia S., Magliocco A., Makretsov N., Gilks B., Pollack J., Huntsman D. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol. Oncol. 2006, 100(2):264-270.
10. Hennessy B.T., Nanjundan M., Cheng K.W., Nolden L., Mills G.B. Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer. Eur. J. Hum. Genet. 2006, 14(4):381-383.
11. Bostner J., Ahnstrom Waltersson M., Fornander T., Skoog L., Nordenskjold B., Stal O. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene 2007, 26(49):6997-7005.
12. Rosen A., Sevelda P., Klein M., Dobianer K., Hruza C., Czerwenka K., Hanak H., Vavra N., Salzer H., Leodolter S., et al. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br. J. Cancer 1993, 67(5):1122-1125.
13. Cheng C.K., Chow L.W., Loo W.T., Chan T.K., Chan V. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res. 2005, 65(19):8646-8654.
14. Sheu J.J., Choi J.H., Yildiz I., Tsai F.J., Shaul Y., Wang T.L., Shih Ie M. The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. Cancer Res. 2008, 68(11):4050-4057.
15. Choi J.H., Sheu J.J., Guan B., Jinawath N., Markowski P., Wang T.L., Shih Ie M. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res. 2009, 69(4):1407-1415.
16. Gautschi O., Ratschiller D., Gugger M., Betticher D.C., Heighway J. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung cancer 2007, 55(1):1-14.
17. Kim J.K., Diehl J.A. Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell Physiol. 2009, 220(2):292-296.
18. Montagut C., Settleman J. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 2009, 283(2):125-134.